New Insights into Acute Stroke using Advanced Imaging

使用高级成像对急性中风的新见解

基本信息

项目摘要

Over the past two decades developments in neuroimaging, especially in magnetic resonance imaging (MRI), have enabled enormous changes to be made in our knowledge and understanding of acute stroke. This knowledge is now being applied and extended in the clinical and translational research of the Stroke Neuroscience Unit at the National Institute of Neurological Disorders and Stroke. A recent advance in clinical MRI is rapid vascular imaging from the aortic arch to the circle of Willis using contrast-enhanced MR angiography (CE-MRA) and a neurovascular array. This has been evaluated and found to be a promising method for the rapid and early detection of extracranial vascular disease. CE-MRA may be added to acute stroke MRI protocols and could be of particular value for emergent decisions regarding acute stroke intervention (intravenous and intra-arterial thrombolysis), urgent surgical intervention and secondary stroke prevention. In new research applications, real-time, high resolution MRI is being combined with peripheral blood markers ? of gene and protein expression and inflammation - to study patterns of stroke risk, evolution and recovery. The peripheral blood is a practical source of samples as brain tissue is rarely available in the clinical setting. In a pilot study of patients with acute ischemic stroke confirmed on neuroimaging studies, a genomic fingerprint of acute stroke was defined and validated in peripheral blood mononuclear cells. The significance and potential applications of these results are under investigation: a 22 gene panel identified from the listing could form a basis for further diagnostic and prognostic fingerprinting of acute stroke. In further studies of the peripheral blood, expansion of a pro-inflammatory subset of T cell lymphocytes (CD4+CD28-) was found to be associated with stroke recurrence and death, in addition to being associated with prior stroke. Expansion of this T cell subset may occur after exposure to brain antigens, and may possibly be involved in the pathophysiological mechanisms leading to recurrent strokes and death. Ongoing and future studies include the correlation of genomic and proteomic profiles with MRI imaging patterns, and evaluation of their potential use for predicting stroke outcome and response to therapeutic interventions. A cohort from the Women?s Health Initiative is being followed to determine if a protein signature can be identified from the peripheral blood to predict future stroke risk. In bedside-to-bench studies, the pathogenic mechanisms and therapeutic potential of biomarkers such as CD4+CD28- are being determined, and promising candidate genes from gene expression profiling studies are being studied in genetic knock-out mouse models of stroke. In conjunction with accurate MR imaging patterns, these approaches may give information on new cellular and pathological mechanisms involved in the etiology and response to acute stroke, allow the development of surrogate biomarkers of stroke risk and prognosis, and ultimately lead to new drug therapies or preventive vaccines.
在过去的二十年里,神经成像的发展,特别是磁共振成像(MRI),使我们对急性中风的认识和理解发生了巨大的变化。这些知识现在正在国家神经疾病和中风研究所中风神经科学部门的临床和转化研究中得到应用和扩展。临床MRI的最新进展是使用对比增强MR血管造影(CE-MRA)和神经血管阵列从主动脉弓到威利斯圈的快速血管成像。这已被评估和发现是一种有前途的方法,快速和早期检测颅内外血管疾病。CE-MRA可以添加到急性卒中MRI方案中,对于急性卒中干预(静脉溶栓和动脉溶栓)、紧急手术干预和二级卒中预防的紧急决策尤其有价值。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Alison E Baird其他文献

Logical Analysis of Data (LAD) model for the early diagnosis of acute ischemic stroke
  • DOI:
    10.1186/1472-6947-8-30
  • 发表时间:
    2008-07-10
  • 期刊:
  • 影响因子:
    3.800
  • 作者:
    Anupama Reddy;Honghui Wang;Hua Yu;Tiberius O Bonates;Vimla Gulabani;Joseph Azok;Gerard Hoehn;Peter L Hammer;Alison E Baird;King C Li
  • 通讯作者:
    King C Li

Alison E Baird的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Alison E Baird', 18)}}的其他基金

mRNA Expression Profiling from Extracellular Vesicles (EVs): Generating a Rapid Diagnostic for Stroke
细胞外囊泡 (EV) 的 mRNA 表达谱分析:快速诊断中风
  • 批准号:
    10445743
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
mRNA Expression Profiling from Extracellular Vesicles (EVs): Generating a Rapid Diagnostic for Stroke
细胞外囊泡 (EV) 的 mRNA 表达谱分析:快速诊断中风
  • 批准号:
    10647755
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
spFRET for Expression Profiling mRNA: Discovering Markers for Stroke Diagnosis
spFRET 用于 mRNA 表达谱分析:发现中风诊断标记物
  • 批准号:
    8228093
  • 财政年份:
    2011
  • 资助金额:
    --
  • 项目类别:
spFRET for Expression Profiling mRNA: Discovering Markers for Stroke Diagnosis
spFRET 用于 mRNA 表达谱分析:发现中风诊断标记物
  • 批准号:
    8040100
  • 财政年份:
    2011
  • 资助金额:
    --
  • 项目类别:
spFRET for Expression Profiling mRNA: Discovering Markers for Stroke Diagnosis
spFRET 用于 mRNA 表达谱分析:发现中风诊断标记物
  • 批准号:
    8427393
  • 财政年份:
    2011
  • 资助金额:
    --
  • 项目类别:
spFRET for Expression Profiling mRNA: Discovering Markers for Stroke Diagnosis
spFRET 用于 mRNA 表达谱分析:发现中风诊断标记物
  • 批准号:
    8606462
  • 财政年份:
    2011
  • 资助金额:
    --
  • 项目类别:
Mechanisms and modifying factors of ischemic brain injur
缺血性脑损伤的机制及影响因素
  • 批准号:
    6671487
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
New Insights into Acute Stroke using Advanced Imaging
使用高级成像对急性中风的新见解
  • 批准号:
    7143919
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Mechanisms and modifying factors of ischemic brain injur
缺血性脑损伤的机制及影响因素
  • 批准号:
    6843283
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
New Insights into Acute Stroke using Advanced Imaging an
使用高级成像对急性中风的新见解
  • 批准号:
    7324715
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似国自然基金

基于DNA甲基化交互网络的癌症hallmark挖掘及其在癌症转移biomarker筛选中的应用
  • 批准号:
    61602201
  • 批准年份:
    2016
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
生物标志物NGAL和KIM-1分子在急性肾损伤中的作用机制研究及标志物联合检测对早期诊断AKI的作用
  • 批准号:
    81101308
  • 批准年份:
    2011
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
血清miRNAs成为一种新的biomarker在PD诊断中的价值和LRRK2基因调控的机制研究
  • 批准号:
    81170309
  • 批准年份:
    2011
  • 资助金额:
    50.0 万元
  • 项目类别:
    面上项目
精神分裂症记忆障碍的脑网络组学研究
  • 批准号:
    91132301
  • 批准年份:
    2011
  • 资助金额:
    350.0 万元
  • 项目类别:
    重大研究计划
卵巢癌血浆microRNA潜在标志物筛选及调控机制研究
  • 批准号:
    81072363
  • 批准年份:
    2010
  • 资助金额:
    32.0 万元
  • 项目类别:
    面上项目
高原人群创伤性深静脉血栓血浆预测诊断蛋白标记物的发掘
  • 批准号:
    81060151
  • 批准年份:
    2010
  • 资助金额:
    25.0 万元
  • 项目类别:
    地区科学基金项目
非小细胞肺癌Biomarker的Imaging MS研究新方法
  • 批准号:
    30672394
  • 批准年份:
    2006
  • 资助金额:
    30.0 万元
  • 项目类别:
    面上项目

相似海外基金

酸化ストレス応答アポトーシス誘導蛋白のUCに対する新規Biomarker探索と治療への展開
寻找治疗 UC 的氧化应激反应性凋亡诱导蛋白的新生物标志物并开发治疗方法
  • 批准号:
    24K11919
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
肝内胆管癌新規Biomarkerの同定及び癌周囲間質を標的とした新規治療開発
鉴定肝内胆管癌的新型生物标志物并开发针对癌周基质的新疗法
  • 批准号:
    24K19350
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
収縮能が保たれた心不全の機械学習分類とmicroRNAなどのbiomarkerの探索
机器学习对具有保留收缩性的心力衰竭进行分类并搜索 microRNA 等生物标志物
  • 批准号:
    24K19007
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Phase Ib/II study of safety and efficacy of EZH2 inhibitor, tazemetostat, and PD-1 blockade for treatment of advanced non-small cell lung cancer
EZH2 抑制剂、他泽美司他和 PD-1 阻断治疗晚期非小细胞肺癌的安全性和有效性的 Ib/II 期研究
  • 批准号:
    10481965
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
Development of a predictive biomarker for Parkinson's disease
帕金森病预测生物标志物的开发
  • 批准号:
    MR/Y019415/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Sleep and circadian dysfunction in ageing and neurodegeneration: a life course and biomarker study of the British 1946 birth cohort.
衰老和神经退行性疾病中的睡眠和昼夜节律功能障碍:对英国 1946 年出生队列的生命历程和生物标志物研究。
  • 批准号:
    MR/Y009452/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
Naturalistic Social Communication in Autistic Females: Identification of Speech Prosody Markers
自闭症女性的自然社交沟通:语音韵律标记的识别
  • 批准号:
    10823000
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
Biomarker-Based Platform for Early Diagnosis of Chronic Liver Disease to Enable Personalized Therapy (LIVERAIM)
基于生物标志物的慢性肝病早期诊断平台,以实现个性化治疗(LIVERAIM)
  • 批准号:
    10087822
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    EU-Funded
Enhanced stratification of COPD patients via integration of a digitally enabled biomarker Point-of-Care test within a Remote Patient Monitoring tool
通过在远程患者监测工具中集成数字化生物标志物即时检测,增强 COPD 患者的分层
  • 批准号:
    10098600
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Collaborative R&D
QuBIE: Quantitative Biomarker Identification for Non-Endoscopic Prediction and Monitoring of Treatment Response in Eosinophilic Oesophagitis
QuBIE:用于非内镜预测和监测嗜酸性食管炎治疗反应的定量生物标志物鉴定
  • 批准号:
    10083253
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Collaborative R&D
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了